Literature DB >> 11015149

Cell-free virus in breast milk of HIV-1-seropositive women.

K Pillay1, A Coutsoudis, D York, L Kuhn, H M Coovadia.   

Abstract

To examine the prevalence, quantification, and factors that influence HIV in the cell-free compartment of breast milk, we performed reverse transcription polymerase chain reaction (RT-PCR) on samples obtained from HIV-1-infected study subjects. Virus was detected in 86 of 136 samples (63.2%) from 79 study subjects. HIV RNA quantity ranged from undetectable to 227,586 copies/ml. Prevalence and mean viral load were not affected by postnatal ages or maternal vitamin A supplementation. Among study subjects with multiple samples, breast milk viral load did not change at different postnatal ages. Breast milk viral load correlated positively with plasma viral load (r = 0.47; p =.005) and negatively with maternal CD4 count at entry to the study (r = -0.26; p =.02). Mothers of HIV-infected children had a higher proportion of detectable HIV RNA in their breast milk than mothers of uninfected children (p =.03) and higher mean log10 HIV RNA quantities (p =.04). In a multivariate logistic regression model, log10 HIV RNA quantity in breast milk was significantly associated with the risk of mother-child transmission (odds ratio [OR], 2.82; 95% confidence interval [CI], 1.22-6.51). Thus, prevention and treatment of opportunistic infections and of mastitis and early weaning may be important elements of a public health policy that is relevant to women in developing countries with HIV infection. Where available, antiretrovirals may also have an impact on opportunistic infections and mastitis.

Entities:  

Mesh:

Year:  2000        PMID: 11015149     DOI: 10.1097/00126334-200008010-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  30 in total

1.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

2.  Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.

Authors:  Charles van der Horst; Charles Chasela; Yusuf Ahmed; Irving Hoffman; Mina Hosseinipour; Rodney Knight; Susan Fiscus; Michael Hudgens; Peter Kazembe; Margaret Bentley; Linda Adair; Ellen Piwoz; Francis Martinson; Ann Duerr; Athena Kourtis; A Edde Loeliger; Beth Tohill; Sascha Ellington; Denise Jamieson
Journal:  Contemp Clin Trials       Date:  2008-09-07       Impact factor: 2.226

3.  Impact of chloroquine on viral load in breast milk.

Authors:  Katherine Semrau; Louise Kuhn; Prisca Kasonde; Moses Sinkala; Chipepo Kankasa; Erin Shutes; Cheswa Vwalika; Mrinal Ghosh; Grace Aldrovandi; Donald M Thea
Journal:  Trop Med Int Health       Date:  2006-06       Impact factor: 2.622

4.  Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted-The Breastfeeding, Antiretrovirals, and Nutrition Study.

Authors:  Nicole L Davis; William C Miller; Michael G Hudgens; Charles S Chasela; Dorothy Sichali; Dumbani Kayira; Julie A E Nelson; Susan A Fiscus; Gerald Tegha; Deborah D Kamwendo; Joseph Rigdon; Jeffrey S A Stringer; Jonathan J Juliano; Sascha R Ellington; Athena P Kourtis; Denise J Jamieson; Charles van der Horst
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

Review 5.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

6.  Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.

Authors:  Michael H Chung; James N Kiarie; Barbra A Richardson; Dara A Lehman; Julie Overbaugh; Grace C John-Stewart
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

7.  Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT.

Authors:  Raabya Rossenkhan; Thumbi Ndung'u; Teresa K Sebunya; Jose E Hagan; Roger Shapiro; Vladimir Novitsky; Sikhulile M Moyo; Ibou Thior; Shahin Lockman; Rebecca Mitchell; Soyeon Kim; Rosemary Musonda; Erik van Widenfelt; Joseph Makhema; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

8.  Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa.

Authors:  Charles Chasela; Ying Qing Chen; Susan Fiscus; Irving Hoffman; Alicia Young; Megan Valentine; Lynda Emel; Taha E Taha; Robert L Goldenberg; Jennifer S Read
Journal:  Pediatr Infect Dis J       Date:  2008-03       Impact factor: 2.129

Review 9.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.

Authors:  Michael H Chung; James N Kiarie; Barbra A Richardson; Dara A Lehman; Julie Overbaugh; Francis Njiri; Grace C John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.